Talanx Valuation
Is 019625225 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 019625225 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 019625225 (CHF38.26) is trading below our estimate of fair value (CHF117.86)
Significantly Below Fair Value: 019625225 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 019625225?
Key metric: As 019625225 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 019625225's PE Ratio? | |
|---|---|
| PE Ratio | 10.7x |
| Earnings | €1.89b |
| Market Cap | €20.30b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 5.5x |
| PEG Ratio | 2.2x |
Price to Earnings Ratio vs Peers
How does 019625225's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 21.5x | ||
HELN Helvetia Holding | 29.3x | 14.3% | CHF 8.0b |
ZURN Zurich Insurance Group | 17.7x | 1.6% | CHF 76.7b |
BALN Bâloise Holding | 29.8x | 14.7% | CHF 7.6b |
VAHN Vaudoise Assurances Holding | 9.3x | n/a | CHF 1.3b |
019625225 Talanx | 10.7x | 4.9% | CHF 20.3b |
Price-To-Earnings vs Peers: 019625225 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the peer average (21.5x).
Price to Earnings Ratio vs Industry
How does 019625225's PE Ratio compare vs other companies in the European Insurance Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 019625225 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the European Insurance industry average (11.8x).
Price to Earnings Ratio vs Fair Ratio
What is 019625225's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10.7x |
| Fair PE Ratio | 21.7x |
Price-To-Earnings vs Fair Ratio: 019625225 is good value based on its Price-To-Earnings Ratio (10.7x) compared to the estimated Fair Price-To-Earnings Ratio (21.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Hannover Rück
€29.1b
Provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally.
HNR1
€159.00
7D
0%
1Y
0%
Vaudoise Assurances Holding
CHF 1.3b
Provides insurance products and services primarily in Switzerland.
VAHN
CHF 462.00
7D
-0.2%
1Y
9.2%
Chubb
US$116.1b
Provides insurance and reinsurance products worldwide.
4432874
US$250.00
7D
0.2%
1Y
23.3%